Hypoglycin A in maple trees in the Netherlands and the risk of equine atypical myopathy

Publication date

2016-05-30

Authors

Westermann, CornélieISNI 0000000393140258
van Leeuwen, Robbert
Mol, Hans

Editors

Advisors

Supervisors

DOI

Document Type

Abstract
Open Access logo

License

Abstract

The Acer (maple) genus of trees comprises over 120 species worldwide. Some of these contain the plant-toxin hypoglycin-A which has been proven to be a cause of the highly fatal condition called atypical myopathy (AM) in horses and ponies. In an earlier study of maple-tree samples (leaves and seeds) collected by owners of healthy and AM-affected horses it was shown that the seeds contain significantly more toxin than the leaves. There is a concern as to whether maple trees can be safely retained or planted around paddocks or pastures, and whether there is a difference in toxicity between different species. The aim of the present study was to investigate the amount of toxin in different maple-tree species present in The Netherlands. The seeds of 20 different tree-species of the ‘Acer’ genus, present in the arboretum in Wageningen, The Netherlands, were analysed for hypoglycin-A; 8 species belonged to the ‘Platanoidea’ subgenus (section), 7 to the ‘Acer’, 3 to the ‘Palmata’ and 2 to the ‘Negundo’ subgenera. Assay was carried out using a newly validated method based on liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Seeds of the maple trees belonging to the ‘Platanoidea’ contained no hypoglycin-A. The seeds of species belonging to the ‘Acer’, ‘Palmata’ and ‘Negundo’ subgenera however contained 96– 1744 mg/kg, 4–32 mg/kg and 3–444 mg/kg of the toxin respectively. These results indicate that the precise tree species is an important aspect when giving advice regarding the toxicity of maple trees and the consequent risk for horses.

Keywords

Citation

Westermann, C M, van Leeuwen, R & Mol, H 2016, 'Hypoglycin A in maple trees in the Netherlands and the risk of equine atypical myopathy', Journal of Veterinary Internal Medicine, vol. 30.